Overview

Botulinum Toxin-A for Hidradenitis Suppurativa

Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if the medication Botulinum Toxin-A (BTX-A) is effective in treating hidradenitis suppurativa (HS)
Phase:
PHASE4
Details
Lead Sponsor:
Yale University
Treatments:
Botulinum Toxins, Type A
Saline Solution